No abstract available
Keywords:
cancer outcome; perioperative management; postoperative complication; prehabilitation; prognosis.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Editorial on the Research Topic Perioperative management and cancer outcome
References
-
-
Nguyen J, Luk K, Vang D, Soto W, Vincent L, Robiner S, et al. Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer. Br J Anaesth (2014) 113(Suppl 1):i4–13. doi: 10.1093/bja/aeu090
-
DOI
-
PMC
-
PubMed
-
-
Du KN, Feng L, Newhouse A, Mehta J, Lasala J, Mena GE, et al. Effects of intraoperative opioid use on recurrence-free and overall survival in patients with esophageal adenocarcinoma and squamous cell carcinoma. Anesth Analg (2018) 127(1):210–6. doi: 10.1213/ANE.0000000000003428
-
DOI
-
PubMed
-
-
Howard R, Yin YS, McCandless L, Wang S, Englesbe M, MaChado-Aranda D. Taking control of your surgery: impact of a prehabilitation program on major abdominal surgery. J Am Coll Surg (2019) 228(1):72–80. doi: 10.1016/j.jamcollsurg.2018.09.018
-
DOI
-
PMC
-
PubMed
-
-
Trepanier M, Minnella EM, Paradis T, Awasthi R, Kaneva P, Schwartzman K, et al. Improved disease-free survival after prehabilitation for colorectal cancer surgery. Ann Surg (2019) 270(3):493–501. doi: 10.1097/SLA.0000000000003465
-
DOI
-
PubMed
-
-
Brennan CA, Garrett WS. Gut microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol (2016) 70:395–411. doi: 10.1146/annurev-micro-102215-095513
-
DOI
-
PMC
-
PubMed